Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Acquired Immunodeficiency Syndrome × Valganciclovir × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 Immune Reconstitution Inflammatory Syndrome 1 Acquired Immunodeficiency Syndrome 1

Interventions

dolutegravir 1 Valganciclovir 1 Ritonavir 1 Radiotherapy 1 Nucleosides 1 Fluconazole 1 Darunavir 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

National Institute of Cancerología

Phase 2 Completed

40 enrolled 6 charts

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡